Decitabine and Cedazuridine Combination Tablets (INQOVI) are a prescription medication used for the treatment of myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML). Due to its specific indications and strict medication requirements, patients need to pay attention to issues such as the legality of purchasing channels, medication administration, and authenticity identification when buying the drug.
How to Purchase Decitabine and Cedazuridine Combination Tablets (INQOVI)
Overseas Purchase
Patients may choose to consult and purchase the drug at hospital pharmacies or official pharmacies in countries or regions where Decitabine and Cedazuridine Combination Tablets have been approved for marketing.
Since drug prices may be affected by factors such as regional differences and exchange rate fluctuations, patients need to make a budget and plan in advance before purchasing.
Purchase Through Medical Service Institutions
Patients may consult domestic overseas medical service institutions that cooperate with international pharmacies or pharmaceutical companies.
These institutions usually provide legal import channels and can offer professional consultation and guidance.
Precautions for Purchasing Decitabine and Cedazuridine Combination Tablets (INQOVI)
Strictly Follow Medical Advice
The dosage and treatment course of Decitabine and Cedazuridine Combination Tablets need to be adjusted according to the patient’s condition, and the drug must be taken strictly as prescribed.
Do not increase, decrease the dosage or interrupt treatment on your own, as this may affect the therapeutic effect or increase the risk of adverse reactions.
Verify Drug Information
Approval number: Check whether the packaging is marked with the approval number from regulatory authorities such as the FDA (e.g., U.S. FDA approval number).
Production information: Genuine products should indicate the manufacturer as "Otsuka Pharmaceutical Co., Ltd." and the distributor as "Taiho Oncology, Inc.".
Be Alert to Illegal Channels
Avoid purchasing through social media or unqualified websites.
Such channels may sell counterfeit drugs, expired drugs, or drugs stored improperly, which endangers medication safety.
How to Identify the Authenticity of Decitabine and Cedazuridine Combination Tablets (INQOVI)
Packaging and Appearance
Characteristics of genuine products: The tablets are biconvex oval film-coated tablets, red in color, with "H35" printed on one side.
Packaging integrity: The original packaging should include an anti-counterfeiting label, batch number, expiration date, and aluminum foil seal, with no signs of damage or tampering.
Official Verification Channels
Query whether the batch number is registered through the official website of drug regulatory authorities (such as the FDA).
Contact the customer service of the manufacturer or distributor to verify the authenticity of the drug.
